Publications dans lesquelles il/elle collabore avec SERAFIN CAMBRAY CARNER (12)

2023

  1. Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study

    Scientific Reports, Vol. 13, Núm. 1

2021

  1. Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study

    Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1043-1054

2020

  1. Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Characteristics of atheromatosis in the prediabetes stage: A cross-sectional investigation of the ILERVAS project

    Cardiovascular Diabetology, Vol. 18, Núm. 1

2018

  1. Metabolomic Estimation of the Diagnosis and Onset Time of Permanent and Transient Cerebral Ischemia

    Molecular Neurobiology, Vol. 55, Núm. 7, pp. 6193-6200

  2. The rs2108622 polymorphism is related to the early risk of ischemic stroke in non-valvular atrial fibrillation subjects under oral anticoagulation

    Pharmacogenomics Journal, Vol. 18, Núm. 5, pp. 652-656

2017

  1. A current estimation of the early risk of stroke after transient ischemic attack: A systematic review and meta-analysis of recent intervention studies

    Cerebrovascular Diseases, Vol. 43, Núm. 1-2, pp. 90-98

2016

  1. Clinical Evolution of Elderly Adults with Ischemic Stroke

    Journal of the American Geriatrics Society

  2. Metabolomics Predicts Neuroimaging Characteristics of Transient Ischemic Attack Patients

    EBioMedicine, Vol. 14, pp. 131-138

  3. The determination of copeptin levels helps management decisions among transient ischaemic attack patients

    Acta Neurologica Scandinavica, Vol. 134, Núm. 2, pp. 140-147

2015

  1. Metabolomics predicts stroke recurrence after transient ischemic attack

    Neurology, Vol. 84, Núm. 1, pp. 36-45

2014

  1. N-terminal pro-brain natriuretic peptide level determined at different times identifies transient ischaemic attack patients with atrial fibrillation

    European Journal of Neurology, Vol. 21, Núm. 4, pp. 679-683